عرض بسيط للتسجيلة

المؤلفChemaitelly, Hiam
المؤلفNagelkerke, Nico
المؤلفAyoub, Houssein H
المؤلفCoyle, Peter
المؤلفTang, Patrick
المؤلفYassine, Hadi M
المؤلفAl-Khatib, Hebah A
المؤلفSmatti, Maria K
المؤلفHasan, Mohammad R
المؤلفAl-Kanaani, Zaina
المؤلفAl-Kuwari, Einas
المؤلفJeremijenko, Andrew
المؤلفKaleeckal, Anvar Hassan
المؤلفLatif, Ali Nizar
المؤلفShaik, Riyazuddin Mohammad
المؤلفAbdul-Rahim, Hanan F
المؤلفNasrallah, Gheyath K
المؤلفAl-Kuwari, Mohamed Ghaith
المؤلفButt, Adeel A
المؤلفAl-Romaihi, Hamad Eid
المؤلفAl-Thani, Mohamed H
المؤلفAl-Khal, Abdullatif
المؤلفBertollini, Roberto
المؤلفAbu-Raddad, Laith J
تاريخ الإتاحة2022-11-09T04:34:51Z
تاريخ النشر2022-09-30
اسم المنشورJournal of Travel Medicine (JTM)
المعرّفhttp://dx.doi.org/10.1093/jtm/taac109
الاقتباسHiam Chemaitelly, PhD, Nico Nagelkerke, PhD, Houssein H Ayoub, PhD, Peter Coyle, MD, Patrick Tang, MD PhD, Hadi M Yassine, PhD, Hebah A Al-Khatib, PhD, Maria K Smatti, MSc, Mohammad R Hasan, PhD, Zaina Al-Kanaani, PhD, Einas Al-Kuwari, MD, Andrew Jeremijenko, MD, Anvar Hassan Kaleeckal, MSc, Ali Nizar Latif, MD, Riyazuddin Mohammad Shaik, MSc, Hanan F Abdul-Rahim, PhD, Gheyath K Nasrallah, PhD, Mohamed Ghaith Al-Kuwari, MD, Adeel A Butt, MBBS MS, Hamad Eid Al-Romaihi, MD, Mohamed H Al-Thani, MD, Abdullatif Al-Khal, MD, Roberto Bertollini, MD MPH, Laith J Abu-Raddad, PhD, Duration of immune protection of SARS-CoV-2 natural infection against reinfection, Journal of Travel Medicine, 2022;, taac109, https://doi.org/10.1093/jtm/taac109
الرقم المعياري الدولي للكتاب1195-1982
معرّف المصادر الموحدhttp://hdl.handle.net/10576/35948
الملخصThe future of the SARS-CoV-2 pandemic hinges on virus evolution and duration of immune protection of natural infection against reinfection. We investigated duration of protection afforded by natural infection, the effect of viral immune evasion on duration of protection, and protection against severe reinfection, in Qatar, between February 28, 2020 and June 5, 2022. Three national, matched, retrospective cohort studies were conducted to compare incidence of SARS-CoV-2 infection and COVID-19 severity among unvaccinated persons with a documented SARS-CoV-2 primary infection, to incidence among those infection-naïve and unvaccinated. Associations were estimated using Cox proportional-hazard regression models. Effectiveness of pre-Omicron primary infection against pre-Omicron reinfection was 85.5% (95% CI: 84.8-86.2%). Effectiveness peaked at 90.5% (95% CI: 88.4-92.3%) in the 7th month after the primary infection, but waned to ~ 70% by the 16th month. Extrapolating this waning trend using a Gompertz curve suggested an effectiveness of 50% in the 22nd month and < 10% by the 32nd month. Effectiveness of pre-Omicron primary infection against Omicron reinfection was 38.1% (95% CI: 36.3-39.8%) and declined with time since primary infection. A Gompertz curve suggested an effectiveness of < 10% by the 15th month. Effectiveness of primary infection against severe, critical, or fatal COVID-19 reinfection was 97.3% (95% CI: 94.9-98.6%), irrespective of the variant of primary infection or reinfection, and with no evidence for waning. Similar results were found in sub-group analyses for those ≥50 years of age. Protection of natural infection against reinfection wanes and may diminish within a few years. Viral immune evasion accelerates this waning. Protection against severe reinfection remains very strong, with no evidence for waning, irrespective of variant, for over 14 months after primary infection.
اللغةen
الناشرOxford University Press
الموضوعCOVID-19
Omicron
cohort study
epidemiology
immunity
reinfection
severe disease
العنوانDuration of immune protection of SARS-CoV-2 natural infection against reinfection.
النوعArticle
ESSN1708-8305
dc.accessType Full Text


الملفات في هذه التسجيلة

Thumbnail

هذه التسجيلة تظهر في المجموعات التالية

عرض بسيط للتسجيلة